Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Carcinoma, Endometrioid

etoposide has been researched along with Carcinoma, Endometrioid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D1
Brainard, J; McBee, WC; Rose, PG; Sawady, J1
Mahmoudi, M; Meyer, T; Nelstrop, AE; Rustin, GJ1

Other Studies

3 other study(ies) available for etoposide and Carcinoma, Endometrioid

ArticleYear
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11

    Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan

2010
Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report.
    Gynecologic oncology, 2007, Volume: 105, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Endometrioid; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ovarian Neoplasms; Vaginal Neoplasms

2007
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Treatment Outcome

2001